Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Mar 6, 2026
- Accession no.
- 0001022079-26-000029
- Filed
- Mar 6, 2026
- Trade date
- Mar 4-5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $799.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | AGrant or awardAcquired | +7,232 | $204.86 | +$1,481,547.52 | 44,789 | Direct | |
| Mar 4, 2026 | Common Stock | FTax withholdingDisposed | −3,354 | $204.86 | −$687,100.44 | 41,435 | Direct | |
| Mar 5, 2026 | Common Stock | SSaleDisposed | −3,878 | $206.21 | −$799,682.38 | 37,557 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.